NCT02159937View on ClinicalTrials.gov

In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Metastatic Cancer
Interventions
OTHER

Blood sampling by vena punction.

In vitro tests will be performed after blood sample collection from metastatic cancer patients

Trial Locations (1)

01246-000

Instituto do Câncer do Estado de São Paulo, São Paulo

All Listed Sponsors
lead

Recepta Biopharma

INDUSTRY

NCT02159937 - In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides | Biotech Hunter | Biotech Hunter